Toxic epidermal necrolysis.
Smith
Lisa Hartkopf
LH
Riverside Methodist Hospital, Columbus, OH, USA. lsmith2@ohiohealth.com
D004999:Amifostine / Q000009:adverse effects*; D001706:Biopsy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D003422:Critical Care; D003937:Diagnosis, Differential; D016903:Drug Monitoring / Q000451:nursing; D006801:Humans; D008297:Male; D008875:Middle Aged; D037981:Neck Dissection; D024802:Nurse's Role; D009730:Nursing Assessment; D009859:Oncology Nursing; D015985:Precipitating Factors; D011837:Radiation-Protective Agents / Q000009:adverse effects*; D018714:Radiotherapy, Adjuvant; D035583:Rare Diseases; D017592:Skin Care; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D014067:Tonsillar Neoplasms / Q000628:therapy
D011837:Radiation-Protective Agents; D004999:Amifostine